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Nerve Growth Factor Partially Recovers Inflamed
Skin from Stress-Induced Worsening in Allergic
Inflammation
Eva M.J. Peters1, Christiane Liezmann1, Katharina Spatz1, Maria Daniltchenko1, Ricarda Joachim1,
Andrey Gimenez-Rivera1, Sven Hendrix2, Vladimir A. Botchkarev3, Johanna M. Brandner4 and Burghard F. Klapp1
Neuroimmune dysregulation characterizes atopic disease, but its nature and clinical impact remain ill-defined.
Induced by stress, the neurotrophin nerve growth factor (NGF) may worsen cutaneous inflammation. We
therefore studied the role of NGF in the cutaneous stress response in a mouse model for atopic dermatitis–like
allergic dermatitis (AlD). Combining several methods, we found that stress increased cutaneous but not serum
or hypothalamic NGF in telogen mice. Microarray analysis showed increased mRNAs of inflammatory and
growth factors associated with NGF in the skin. In stress-worsened AlD, NGF-neutralizing antibodies markedly
reduced epidermal thickening together with NGF, neurotrophin receptor (tyrosine kinase A and p75 neuro-
trophin receptor), and transforming growth factor-b expression by keratinocytes but did not alter
transepidermal water loss. Moreover, NGF expression by mast cells was reduced; this corresponded to
reduced cutaneous tumor necrosis factor-a (TNF-a) mRNA levels but not to changes in mast cell degranulation
or in the T helper type 1 (Th1)/Th2 cytokine balance. Also, eosinophils expressed TNF receptor type 2, and we
observed reduced eosinophil infiltration after treatment with NGF-neutralizing antibodies. We thus conclude
that NGF acts as a local stress mediator in perceived stress and allergy and that increased NGF message
contributes to worsening of cutaneous inflammation mainly by enhancing epidermal hyperplasia, pro-allergic
cytokine induction, and allergy-characteristic cellular infiltration.
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INTRODUCTION
The association between stress and the worsening of atopic
disease is widely accepted and generally attributed to neuro-
immune dysregulation. Two parallel observations contributed
to the generation of this conviction (c.f. Theoharides and
Kalogeromitros, 2006): (i) allergic inflammation is character-
ized by mast cell degranulation and altered neuropeptide
levels (Sugiura et al., 1992; Black, 2002; Huang et al., 2003;
Peters et al., 2006a; Cevikbas et al., 2007) and (ii) stress is
able to degranulate mast cells in a neuropeptide-dependent
manner even when generated by nonphysical, noninflamma-
tory, perceived stressors such as noise or restraint (Singh
et al., 1999; Peters et al., 2005, 2006a; Arndt et al., 2008).
From these observations, it was concluded that stress leads to
neurogenic inflammation, which in turn can worsen allergic
inflammation, albeit scientific proof of this hypothesis was
unavailable (Peters et al., 2006a; Arndt et al., 2008).
Recently, we confirmed that acutely administered stress
employs neurogenic inflammation to worsen allergic inflam-
mation in loco in a mouse model of atopic dermatitis–like
allergic dermatitis (AlD; Pavlovic et al., 2008). Neurogenic
inflammation thereby initiates classic features of atopic
dermatitis development and chronification, such as epider-
mal thickening, infiltration by eosinophils, and altered
cytokine balance, and it depends on substance P (SP)
signaling (Pavlovic et al., 2008), a neuropeptide mediator of
the cutaneous stress response.
Neurotrophin nerve growth factor (NGF) contributes to
cutaneous innervation development and turnover (Tominaga
et al., 2009) and maintains SPþ nerve fibers in the skin
(Botchkarev et al., 2004; Schulte-Herbruggen et al., 2007). It
is also involved in stress-induced cutaneous hyperinnervation
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(Peters et al., 2007) and induces keratinocyte proliferation
(Botchkarev et al., 2004), mast cell degranulation (Tal and
Liberman, 1997), and alterations of the cytokine balance
that promote allergic inflammation (Bonini et al., 2003).
Taken together, these findings show that NGF is potentially a
key molecule that affects all hallmarks of allergic inflamma-
tion and cutaneous stress responsiveness upstream of SP
(Botchkarev et al., 2006; Peters et al., 2007).
In this study, we therefore characterized NGF function in the
cutaneous stress response during allergic inflammation. We
determined the impact and mechanisms by which NGF alters
stress-induced exacerbation of AlD in the established murine
AlD-stress model (Pavlovic et al., 2008). With this approach, we
intend to clarify the potential and predominant mechanism
by which NGF acts as a stress mediator in allergic inflammation,
with the aim of identifying key features of disease pathology that
can be improved by NGF neutralization.
RESULTS
AlD and noise stress increase NGF expression in murine
telogen skin
We first sought to determine the impact of noise stress on local
and systemic NGF production in telogen mice. We found that
NGF mRNA expression in the hypothalamus (Figure 1a) and
NGF serum levels (Figure 1b) were unaltered 48hours after
termination of stress exposure. By contrast, stress increased
cutaneous NGF transcription and immunoreactivity especially in
epithelial structures and mast cells in the skin of stressed mice as
compared with unaffected, unstressed controls (Figure 1c).
Microarray analysis of stressed skin reveals upregulation of
NGF-associated growth factor and inflammatory signaling
To gain a general idea of the inflammation-modulating effects of
NGF under stress, we employed the Affymetrix Mouse Genome
430A 2.0 Array (Santa Clara, CA). We analyzed 22,600 probe
sets representing 14,000 genes. Of these genes, the expression
of 272 was upregulated and that of 416 downregulated after
stress exposure. A fold change 42 was considered significant.
Among these regulated genes, Kyoto Encyclopedia of Genes
and Genomes analysis revealed pathways involved in processes
such as neuronal maintenance, focal adhesion, and inflamma-
tion, all of which may be affected by altered NGF signaling. We
selected 76 genes for focused analysis, including interacting
growth factors as well as cytokines and adhesion molecules
reported to be modulated by NGF. None was downregulated
whereas gene expression of transforming growth factor-b
(TGF-b) 2, tumor necrosis factor receptor type 1B (TNFRIB
encoding TNFRII), and vascular endothelial growth factor A and
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Figure 1. Nerve growth factor (NGF) is increased in skin but not in serum or
hypothalamus. (a) In the hypothalamus, the key brain area mediating stress,
stress did not alter NGF mRNA levels. (b) In the serum, NGF protein level
was unaltered by stress. (c) In the skin, stress exposure leads to a strong albeit
not significant increase in NGF mRNA. Immunohistochemistry (IHC)
confirms the mRNA data on protein level and demonstrates a significant
increase in epidermal NGF expression. Representative photomicrographs of
epidermal and mast cell NGF expression (red) are given below the
corresponding mRNA levels. Fluorescein isothiocyanate counterstaining
reveals identity of mast cells. Arrows point at NGFþ mast cell in
stressed dermis. d, dermis; e, epidermis; hfe, hair follicle epithelium;
IR, immunoreactivity. Cell nuclei are counterstained with
40,6-diamidino-2-phenylindol (blue). **P-values o0.01. Bar¼ 50mm.
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C were significantly upregulated in the skin of stressed mice
(Supplementary Table S1 online).
Anti-NGF treatment reduces epidermal NGF, NGF receptor,
and TGF-b2 expression and epidermal thickening, but not
transepidermal water loss
We next assessed epithelial NGF and NGF receptor expres-
sion as well as that of the epithelial growth factors highlighted
by the above microarray analysis. By quantitative immuno-
morphometry, NGF was significantly increased in the
epidermis of stressed AlD over AlD mice (Figure 2a). Also,
proNGF—the biologically active precursor molecule of
NGF—was detectable only in stressed AlD skin (Figure 2a).
Expression of tyrosine kinase A (TrkA)—the high-affinity
receptor for NGF with high epidermal proliferative poten-
tial—was strongest in epidermal keratinocytes. In control
epidermis, TrkA immunoreactivity highlighted exclusively the
basal layer (Peters et al., 2006b), whereas in the stressed AlD
skin, the staining spread over all epidermal layers (Figure 2b).
Expression of p75 neurotrophin receptor (p75NTR)—the low-
affinity NGF receptor and enhancing co-receptor of TrkA—
(Figure 2c) as well as that of TGF-b2 (Figure 2d) followed the
pattern of NGF with the highest staining intensity in the
epidermis of stressed AlD mice. Semiquantitative histomor-
phometric analysis of expression intensity revealed an
additive effect of stress on AlD expression patterns. Treatment
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Figure 2. NGF modulates growth factor expression and epidermal hyperplasia but not transepidermal water loss (TEWL). AlD skin shows prominent epidermal
immunoreactivity for (a) nerve growth factor (NGF), (b) tyrosine kinase A (TrkA), (c) p75 neurotrophin receptor (p75NTR), and (d) transforming growth
factor-b (TGF-b) 2. After stress, increased expression of NGF (a–d) and proNGF (gray transparent bar in a) is reverted after treatment with anti-NGF (a–d).
(e) AlD epidermis is multilayered and thickened to more than 20 mm by stress. Stress exposure markedly and significantly increased epidermal thickness and
produced prominent spongiosis, which could be reverted with anti-NGF. (f) Stress did not induce a significant increase in AlD-enhanced TEWL nor did the
treatment with NGF-neutralizing antibodies improve barrier function. Representative photomicrographs are shown below the respective statistical analysis.
aNGF, anti-NGF neutralizing antibody; d, dermis; e, epidermis. *Po0.05. Bar¼ 50mm.
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with NGF-neutralizing antibody was sufficient to reduce
NGF, proNGF, TrkA, and p75NTR as well as TGF-b2
immunoreactivity to AlD levels without stress exposure
(Figure 2a–d).
We had previously shown that epidermal thickening is a
useful readout parameter for assessing dermatitis severity
after stress exposure in AlD mice (Pavlovic et al., 2008). In
the present study we confirmed a significant increase (by
more than 30%) in epidermal thickness after stress exposure
(Pavlovic et al., 2008). Furthermore, we observed that treat-
ment with NGF-neutralizing antibodies reduced epidermal
thickness to AlD levels without stress exposure (Figure 2e).
Altered epidermal thickness is frequently associated with a
disruption of epidermal barrier function, which is also a
characteristic feature and indicator of disease severity in
cutaneous allergic inflammation (Takahashi et al., 2005;
Gupta et al., 2008). We therefore assessed baseline transe-
pidermal water loss (TEWL) as a measure of epidermal barrier
disruption. We were able to detect increased TEWL in
stressed mice and most strikingly in AlD mice as compared
with controls (control: 4.76 g per hour per m2, stress: 6.28 g
per hour per m2, AlD: 10.91 g per hour per m2). However,
barrier function was not significantly further disturbed by
stress in AlD mice, nor was it affected by treatment of stressed
AlD mice with NGF-neutralizing antibodies (Figure 2f).
Mast cell expression of NGF but not mast cell degranulation is
reduced by treatment with anti-NGF
To assess the impact of NGF on relevant innate immune
responses in allergy, we focused on mast cells and found that
absolute mast cell numbers are unaffected by our experimental
protocol. Compared with untreated controls, we observed a
significant increase in the NGF immunoreactivity of dermal and
subcutaneous mast cells as well as in the percentage of NGFþ
mast cells in both AlD and stressed AlD mice (not shown). When
AlD mice were compared with stressed AlD mice, stress did not
further enhance NGF expression by mast cells (Figure 3a). By
contrast, mast cell degranulation, as a sign of enhanced neuro-
genic inflammation, was prominently increased by stress in
AlD mice (Figure 3b; Pavlovic et al., 2008). Anti-NGF treatment
significantly reduced the number of NGFþ mast cells in stressed
AlD mice (Figure 3a), but did not reduce the percentage of
degranulated mast cells in AlD skin after stress exposure
(Figure 3b), which shows that altered NGF expression is not asso-
ciated with altered mast cell numbers or mast cell degranulation.
TNF-a but not T helper 1/2 cytokine production is altered by
anti-NGF
Using quantitative real-time PCR, we determined the mRNA
levels of the classic T helper type 1 (Th1) cytokine IFN-g or
the classic Th2 cytokines IL-4 and IL-5 to assess cytokine
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Figure 3. Anti-nerve growth factor (NGF) downregulates NGF immunoreactivity in mast cells but does not affect mast cell degranulation. (a) Treatment with
NGF-neutralizing antibodies markedly reduced the NGF immunoreactivity (red label) in fluorescein isothiocyanate-avidinþ (green label) mast cells (MC;
arrows) as well as the percentage of NGF-immunoreactive mast cells. NGFþ mast cells were also identified by tryptase staining. (b) Stress increased the
percentage of degranulated mast cells in the dermis and subcutis of mice with AlD, but treatment with anti-NGF did not bring down mast cell degranulation.
Giemsa staining reveals multiple extracellular mast cell granules in the back skin of both stressed AlD mice and anti-NGF-treated stressed AlD mice (arrows,
boxes indicate magnifications as shown below). aNGF, anti-NGF neutralizing antibody. *Po0.05; **Po0.01. Bar¼ 50 mm.
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balancing. These parameters did not show significant
differences between stressed AlD mice and anti-NGF-treated
stressed AlD mice (Figure 4). A quotient build from Th1/Th2
cytokines using the formula IFN-g/(IL-4þ IL-5)/2) did not
reveal a significant shift in the cytokine balance (AlD¼ 1,
stressþAlD¼ 1, stressþAlDþ anti-NGF¼0.9). By contrast,
the mainly mast cell–derived pro-inflammatory cytokine
TNF-a was markedly and significantly reduced by anti-NGF
treatment (Figure 4).
Eosinophils are reduced by anti-NGF
Finally, we analyzed skin infiltration by eosinophils, a crucial
hallmark of cutaneous allergic inflammation (Pavlovic et al.,
2008). Immunohistochemistry revealed that skin-infiltrating
eosinophils stained weakly positive for p75NTR (not shown)
and strongly positive for TNF receptor type 2 (TNFRII) in all
experimental groups, with the strongest expression in AlD
mice (Figure 5a). Again, treatment with NGF-neutralizing
antibodies significantly reduced cutaneous eosinophil infil-
tration in the dermis and subcutis of stressed AlD mice to
levels measured in AlD without stress exposure (Figure 5b).
DISCUSSION
Using our mouse model of stress and AlD with analogy to
human extrinsic atopic or allergic dermatitis, we obtained
conclusive evidence of a role for NGF in stress-induced
worsening of allergic inflammation. Specifically, we found
that NGF is involved in the enhancement of epidermal
hyperplasia, TNF-a expression, and eosinophilia under stress
but does not contribute to epidermal barrier dysfunction,
mast cell degranulation, or alteration of the Th1/Th2 cytokine
balance. It accounts for a stress-induced worsening of disease
parameters byB30–50%. Furthermore, our data document a
therapeutic effect of anti-NGF treatment on stress-induced
exacerbation of peripheral inflammatory events.
Supporting a role for NGF in allergy and stress, increased
NGF levels were reported in atopic individuals and NC/Nga
mice, a mutant developing spontaneous AlD-like lesions
(Toyoda et al., 2002; Takano et al., 2007), as well as in
stressed healthy individuals (Aloe et al., 1994; Alleva et al.,
1996), whereas relaxing activities led to a reduction in both
disease activity and NGF levels (Kimata, 2004; Takano et al.,
2005; Tominaga et al., 2009). In the NC/Nga mouse, topical
treatment with TrkA antagonists downregulated epidermal
TrkA as well as NGF, and anti-NGF treatment reduced
epidermal thickening (Takano et al., 2005). In this study, we
observed an additive effect of AlD and stress on NGF
expression, which can be specifically downregulated by anti-
NGF treatment together with stress enhancement of epider-
mal hyperplasia. This observation indicates the existence of a
positive-feedback loop in stress-induced epidermal NGF
signaling, which can be specifically blocked by anti-NGF
treatment (Spillantini et al., 1989).
As players in the innate immune response, mast cells have
long been shown to synthesize, store, and release NGF,
particularly in the context of inflammation (Leon et al., 1994;
Groneberg et al., 2005). In our experiments, mast cells
express NGF and p75NTR and downregulate NGF expression
after anti-NGF treatment. Intriguingly, this corresponds to
cutaneous TNF-a levels but not mast cell degranulation
(Black, 2002; Steinhoff et al., 2003; Pavlovic et al., 2008).
This observation is in good agreement with a recent report
indicating that physiological concentrations of NGF do not
directly induce mast cell degranulation (Kulka et al., 2008).
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Figure 4. Anti-nerve growth factor (NGF) decreases tumor necrosis factor (TNF)-a mRNA levels in AlD skin. Values are expressed in relation to AlD
levels when AlD equals 1. Treatment by NGF-neutralizing antibodies did not affect mRNA levels of IFN-g, IL-4, or IL-5 when compared with stressed AlD
full-thickness skin extracts. By contrast, anti-NGF treatment significantly reduced TNF-a levels. *Po0.05. aNGF, anti-NGF neutralizing antibody.
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Previously reported biological effects of NGF on mast cell
degranulation in the skin may thus reflect NGF-induced
relative peptidergic hyperinnervation (Davies et al., 1987;
Kinkelin et al., 2000; Peters et al., 2004).
Finally, several in vitro reports indicate that NGF may
promote a bias toward the production of Th2 cytokines
(Braun et al., 1998; Tokuoka et al., 2001), which are promi-
nently involved in atopy as well as in chronic stress responses
(Pavlovic et al., 2008). Intriguingly, our data do not support
this hypothesis because we did not see any substantial
alteration of Th1 or Th2 cytokines after treatment with anti-
NGF. This unexpected finding underscores the necessity of
analyzing biological function in the context of living
organisms, so that all potentially counterregulating pathways
that determine clinical outcome are present.
With respect to the skin infiltration by eosinophils, which
express p75NTR and TrkA receptor (Nassenstein et al., 2003;
Raap et al., 2005; Hahn et al., 2006), we observed p75NTR
receptor expression on eosinophils and decreased NGF levels
corresponding to the significant downregulation of cutaneous
eosinophil granulocyte infiltration by anti-NGF treatment of
stressed AlD mice. These results provide first evidence for a
functional role for NGF in eosinophil granulocyte infiltration
of the allergically inflamed skin in response to stress.
Finally, in healthy skin, TNF-a is exclusively located on
mast cells (Ackermann and Harvima, 1998), and the number
of TNF-aþ mast cells is increased in lesional human AlD
skin (Ackermann and Harvima, 1998). TNF-a participates in
eosinophilic infiltration of the skin (Thomas, 2001) and may
further enhance cutaneous NGF expression (Hattori et al.,
1993). In our experiments, TNFRII was detected on eosino-
phils, and after anti-NGF treatment, TNF-a was markedly and
significantly reduced together with NGF in stressed AlD skin,
indicating a close association between both their expression
patterns and their capacity to promote eosinophil survival.
These findings indicate that targeting NGF signaling can
be an important therapeutic tool to prevent lichenification
and chronic allergic inflammation in the skin, especially in
response to stress. Figure 6 illustrates selected NGF effects
directly exerted on epidermal hyperplasia and eosinophil
granulocyte infiltration, mast cell NGF and TNF-a signaling,
and NGF control of neuronal plasticity, leaving mast cell
degranulation and cytokine balance out of the cycle. This
insight into NGF function in allergic inflammation and the
cutaneous stress response explains why anti-NGF treatment
does not recover all atopic symptoms (Takano et al., 2005).
Thus, future treatment strategies aiming at neurogenic inflam-
mation should consider a combination of pharmaceuticals
that affect different aspects of the neuroimmune cross-talk,
such as NGF and SP.
MATERIALS AND METHODS
Animals
Female C57BL/6 mice (Charles River; Sulzfeld, Germany) were
randomly distributed into five experimental groups (control, stress,
AlD, stressþAlD, anti-NGFþ stressþAlD) and left for 1 week to
adjust to their new environment at the animal facility, University
Medicine Charite´, Virchow Campus, Berlin, Germany (Paus et al.,
1997, 1998; Peters et al., 2005; Pavlovic et al., 2008). Animal care
and experimental procedures were approved by the institutional
review board and conformed to the requirements of the state
authority for animal research (LaGetSi, Berlin, Germany).
The AlD-Stress Model
As described previously (Sawada et al., 1997; Cho et al., 2001;
Pavlovic et al., 2008), mice were sensitized to ovalbumin (20mg,
grade VI, Sigma-Aldrich Chemie, Schnelldorf, Germany) on days 7
and 28 of the experimental protocol. AlD was induced by
intradermal injection of ovalbumin (50 mg, grade V, Sigma-Aldrich
Chemie) on day 35. In the stress protocol, mice were exposed to
noise (300Hz tone emitted at irregular intervals four times per
minute; rodent repellent device, Conrad Electronics, Hirschan,
Germany) for a single 24-hour period (Peters et al., 2004, 2005;
Overlay
TNFRII FITC avidin DAPIa
**
70
**
60
50
40
30
20
10
0
AlD Stress
+ AlD
Stress + AlD
+ aNGF
b
Eo
si
no
ph
ils
Eo
si
no
ph
ils
 p
er
 m
icr
os
co
pi
c 
fie
ld
St
re
ss
+A
lD
Figure 5. Anti-nerve growth factor (NGF) effectively reduces the number of
eosinophil granulocytes in stressed AlD skin. (a) Eosinophils were strongly
immunoreactive for tumor necrosis factor receptor type 2 (TNFRII; arrow
in insert, indicated by dotted lines) in all groups. A representative
photomicrograph of the dermis of a stressed AlD mouse is shown.
(b) Stress increased the number of eosinophil granulocytes infiltrating the
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subcutis border as detected by Giemsa staining (arrows). **Po0.01.
aNGF, anti-NGF neutralizing antibody. Bar¼ 50mm.
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Pavlovic et al., 2008). Stress exposure immediately preceded
cutaneous ovalbumin challenge. Mice were killed 48 hours after
challenge or after termination of stress exposure.
Application of anti-NGF
Two hundred microliters of polyclonal rabbit anti-mouse NGF
antibody (Sigma-Aldrich, Munich, Germany) was injected intra-
peritoneally twice in stressed AlD mice, at a dilution of 1:1,500
in phosphate-buffered saline. The injections were administered just
before and immediately after stress exposure. The second injection
preceded AlD induction by 30minutes. According to the manufac-
turer, a 1:4,000 dilution of this antibody blocks bioactivity of
5 ngml1 NGF. The dosage of anti-NGF at 1:1,500 was based on
previously published data (Peters et al., 2004). We employed this
NGF-blocking approach rather than NGF-receptor blockade be-
cause the complex interplay between NGF and its receptors TrkA
and p75NTR requires blockade of the ligand in an in vivo setting to
target biologically relevant interaction. Likewise, a transgenic
approach to targeting the role of NGF can focus only on individual
receptors owing to the lethality of the NGF knockout mutation
(Conover and Yancopoulos, 1997).
Tissue collection
For immunohistochemistry, mice were perfusion-fixed using a
mixture of paraformaldehyde and picric acid (Botchkarev et al.,
1997; Peters et al., 2002). For purposes of microarray and
quantitative real-time PCR, mice were killed by cervical dislocation
and the skin was immediately snap-frozen.
RNA isolation, DNAse treatment, reverse transcription, and
real-time PCR
About 100mg of skin tissue from each of three mice per group was
treated with 1ml Trizol (Invitrogen, Karlsruhe, Germany). The total
RNA was extracted and treated with 1U DNAse I per microgram of
RNA (Invitrogen), followed by inactivation with EDTA (Invitrogen).
There was no detection of genomic DNA via PCR. First-strand cDNA
synthesis was performed using Superscript II reverse transcriptase
(Invitrogen). Quantitative real-time PCR was employed to obtain
quantitative data on differences in NGF, pre-protachikinin 1
(precursor mRNA encoding SP), IL-4, IL-5, TNF-a, and IFN-g mRNA
expression between experimental groups. This assay exploits the
50-nuclease activity of AmpliTaq Platin (Invitrogen) DNA polymerase
to cleave a fluorogenic probe designed for the above transcripts
(TipMolBiol, Berlin, Germany). The quantitative real-time PCR reac-
tions were normalized to hypoxanthine phosphoribosyl transferase
(HPRT) by calculating the difference between the CT for HPRT
and the CT for the respective transcript as DCT¼CT HPRTCT
transcriptCT. The amount of mRNA was calculated as 1/2DCT and
expressed as the difference from control or the CT detected in AlD,
set as 1. Each sample was analyzed in duplicate.
Microarray analysis
A total of three mice were pooled for the untreated control and the
stress groups. In all, 90 ng of total RNA of each skin sample was
applied for two rounds of RNA amplification with RiboAmp RNA
Amplification Kit (Arcturus, Sunnyvale, CA) and antisenseRNA was
biotin labeled with a BioArray HighYield RNA Transcript Labeling Kit
Anti-NGF
Tissue
hyerplasia
Neuronal
plasticityNGF
Enhanced by
stress and
inflammation  Structural
cell growth
Increased
nerve–target
interaction
Mast cell
NGF
expression 
Cytokine
balanceEosinophilic
infiltration
Mast cell
degranulation
Inflammatory
immune
response
Mast cell
TNFα
production 
Figure 6. Hypothetical scenario of nerve growth factor (NGF) signaling in stressed allergic skin. NGF shown in the center of its biological functions in skin, all
of which are affected in stressed skin and in atopic dermatitis–like allergic dermatitis (AlD). By blocking NGF signaling, anti-NGF can effectively block all
affected NGF interactions in stressed AlD skin.
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(ENZO Diagnostics, Farmingdale, NY). A total of 10mg of antisense
RNA was hybridized to Gene Chip Mouse Genome 430A 2.0
(Affymetrix; inquires for B14,000 murine genes) arrays using standard
Affymetrix protocols. Raw data were log2 transformed and quintile
normalized, and expression levels were calculated using Affymetrix
Microarray Suite (MAS) 5.0 and Operating Software GCOS 1.4
(Affymetrix, Santa Clara, CA). Genes were annotated employing the
NetAFFX analysis center (http://www.affymetrix.com/analysis/index.
affx). Pathway and gene ontology analysis was done using Database
for Annotation, Visualization and Integrated Discovery 2007 (Dennis
et al., 2003; Hosack et al., 2003).
ELISA
Serum NGF was measured with a ChemiKine murine NGF ELISA kit
(Chemicon, Temecula, CA; 410pgml1) according to the manufac-
turer’s instructions. Briefly, serum was collected from five or six animals
per group. A total of 100ml standard or serum per well was incubated
overnight at 4 1C and labeled by peroxidase-anti-NGF-antibodies
for 2hours at room temperature, followed by 3,30,5,50-tetramethyl-
benzidine substrate addition. The reaction was stopped after 15minutes
by adding HCl, and the plate was immediately read with the help of a
standard ELISA reader (BMG Labtech, Jena, Germany) at 450nm. Data
were evaluated using the Optima Program with the Optima Microplate
Reader (BMG Labtech).
Routine histochemistry
Epidermal thickness and the presence of eosinophils and mast cell
degranulation in back skin from five or six mice per group were
determined on 10-mm thick sections processed for Giemsa staining
(Merck, Darmstadt, Germany) in a standard method according to
previously published protocols (Botchkarev et al., 1997; Peters et al.,
2005; Pavlovic et al., 2008). Cells were classified as eosinophils
when they showed the classic eosinophil granulocyte cytoplasm and
ring-like nuclei. Mast cells were classified as ‘‘degranulated’’ when
eight or more granules could be found outside the cell membrane.
Immunofluorescence
NGF, TrkA, p75NTR, TGF-b2, and TNFRII immunoreactivity was
determined in 10-mm thick sections from five or six mice per group.
Primary antibody binding (NGF antiserum, polyclonal, 1:100; TrkA
antiserum, polyclonal, 1:100; TGF-b2 antiserum, polyclonal, 1:50, all
acquired from Santa Cruz, Heidelberg, Germany; p75NTR antiserum,
polyclonal, 1:100, acquired from Chemicon; TNFRII antiserum,
polyclonal, 1:50, acquired from Promo Kine, Heidelberg, Germany)
was detected either by a rhodamine-labeled secondary antibody
(Dianova, Hamburg, Germany, dilution 1:200) or by tyramide amplifi-
cation (Renaissance TSAFM-Direct (Red); NENTM Life Science
Products, Boston, MA; Pavlovic et al., 2008). NGF was also counter-
stained with tryptase to verify the immunoreactivity of mast cells (MCP6
antiserum, polyclonal, 1:100, R&D Systems, Wiesbaden, Germany).
Nuclei were counterstained with 40,6-diamidino-2-phenylindol and
mast cells with fluorescein-labeled streptavidin.
Qualitative histomorphometry
Epidermal thickness and immunoreactivity to the above listed
antibodies and number of eosinophils, degranulated mast cells,
and immunoreactive mast cells, as well as immunoreactivity of
eosinophils, were determined in the center of the AlD lesion
(Pavlovic et al., 2008). For each experimental group, at least 10
microscopic fields per mouse of five or six mice per group were
studied at a magnification of  400 (i.e., more than 50 microscopic
fields were studied for each parameter and experimental group).
Representative staining patterns were photodocumented using a
digital imaging device (Visitron Systems, Puchheim, Germany).
TEWL
To prepare the test area, the flanks of the five mice per group were
shaved, avoiding any damage to the skin. Two days later, TEWL was
evaluated in the shaved areas using a C&K Tewameter TC350
(CourageþKhazaka, Cologne, Germany). The mean TEWL values
were internally recalculated every 2 seconds by the Tewameter, and
values were recorded after an overall measurement time of 1minute.
Measurements were made under standardized conditions (tempera-
ture 22–24 1C, constant air humidity (40–50%), minimal air move-
ment, no direct exposure to light).
Statistical analysis
Means were calculated and significant differences were determined
with the Mann–Whitney U-test for unpaired samples. Significance
was assumed if *Po0.05 or **Po0.01.
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